Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Law Offices of Howard G. SmithFractyl Health, Inc. (GUTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitThe Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Fractyl Health, Inc. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FRACTYL...
- B. Braun Medical Inc.B. Braun Medical Launches Introcan Safety® 2 Deep Access IV CatheterNew longer-length IV catheter, designed to increase catheter dwell time, offers fully automatic, passive needlestick protection and multi-access blood control — B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain...
- Lightbeam Health SolutionsLightbeam Health Solutions and ChartSpan Partner to Unify Device-Based and Deviceless Remote Patient Monitoring Within Value-Based CareNew partnership enables a scalable, multi-modal approach to patient monitoring, addressing fragmented data and workflows in value-based care — Lightbeam Health Solutions, the proven AI-enabled solutions and services leader helping healthcare...
- Mark Sturdevant, M.D., Named to Lead Scripps Center for Organ and Cell TransplantationTransplant surgeon brings extensive clinical, research and academic experience
- Blue Shield of CaliforniaBlue Shield of California Expands Medicare Offerings for 2027 with New Plans, Enhanced Benefits, and Digital ToolsThe nonprofit health plan provides a wide range of options designed to fit Medicare-eligible Californians' lifestyle, budget, and health goals — Blue Shield of California today announced its 2027 Medicare plans, offering eligible Californians...
- Stonegate, Inc.Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). IXHL's FY26 update moves the IHL-42X story from DReAMzz preparation into active clinical execution, with first-patient dosing underway and the balance sheet providing runway for at least 12 months of planned operations. The study is evaluating approximately 120 patients across nine dose combinations...
- ARMS MedicalARMS Medical's VNEW® Named MedTech Outlook's Pelvic Floor Surgery Technology of 2026ARMS Medical today announced that VNEW®, its patented, mesh-free dermal allograft designed specifically for female pelvic floor reconstruction, has been named MedTech Outlook's Top Pelvic Floor Surgery Technology of 2026. VNEW was...
- Candel Therapeutics Announces Publication of Phase 2a Trial Data that Demonstrated Prolonged Survival after Systemic Immune Reactivation by Aglatimagene Besadenovec plus Valacyclovir in Patients with Unresectable Stage III/IV NSCLC with an Inadequate Response to ICICandel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced the publication of final phase 2a clinical trial results (NCT04495153) of aglatimagene besadenovec (aglatimagene) plus valacyclovir in patients with stage III/IV NSCLC who had shown inadequate response to ICI. The trial demonstrated a median overall survival (mOS) of 24.5 months in the evaluable population, substantially exceeding historical benchmarks for standard-of-care docetaxel chemotherapy in this patient population.
- BrightSpring Health Services, Inc.BrightSpring Health Services, Inc. to Announce Third Quarter 2026 Financial Results on October 30, 2026Companies: BrightSpring Health ServicesBrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2026 financial results on Friday, October 30, 2026, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day.
- OracleOracle and King Faisal Specialist Hospital & Research Centre to Advance Healthcare Innovation in Saudi ArabiaCompanies: Oracle CorporationAustin, Texas—Oct 1, 2026 Oracle Health and King Faisal Specialist Hospital & Research Centre (KFSH) today announced a shared interest, under a non-binding memorandum of understanding, in exploring a strategic collaboration to build an intelligent, continuously learning healthcare ecosystem that connects clinical, genomic, and research data. By combining KFSH’s clinical and research capabilities with Oracle’s cloud,
- PharmaTher Holdings Ltd.PharmaTher Enters into Exclusive North American Distribution Agreement with Craft Health for CraftMake(TM) Pharmaceutical 3D Printing PlatformHighlightsPharmaTher is now the exclusive distributor in North America of Craft Health's CraftMake™ 3D printers, CraftControl™ software, CraftBlends™ printable formulations, consumables, and service.Exclusivity covers every key customer segment: compounding pharmacies (503A and 503B), telehealth and digital health companies, CDMOs, hospitals, academic, research, and government institutions, and pharmaceutical, biotechnology, and healthcare companies.PharmaTher estimates more than 10,000...
- SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion CapabilitySpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”) announced today the acquisition of all the outstanding shares of common stock of Advanced Vision Science, Inc. (AVS), an ophthalmic medical device company and manufacturer of intraocular lenses (IOLs) and lens materials, for approximately $13 million in cash. This acquisition secures scalable commercial IOL manufacturing capacity for SpyGlass Pharma. AVS was a wholly owned subsidiary of Santen Pharmaceutical Co., Ltd (Santen) and is the current supplier of SpyGlass Pharma’s IOL in its two Phase 3 registrational trials evaluating the BIM-IOL System.